14 Nov 2007: BioPharm Insight™ by Infinata, a leading provider of Life Science Industry information and insight, today announced significant enhancements to their BioPharm Insight online database product. The latest release of BioPharm Insight now includes proprietary Pharmawire intelligence, enabling users to gain greater intelligence and insight to capitalize on current and future opportunities in their business.
“We’re very excited to offer our BioPharm Insight customers access to proprietary Pharmawire Intelligence. Through a global network of journalists, we’re now tapping into leading CEOs, Scientists, Clinicians, Lawyers, and other experts on a daily basis to provide insight into drug licensing pipelines, merger and acquisition pipelines, patent expirations, and key litigation events,” said Sean Power, President of Infinata, Inc.
BioPharm Insight customers will also have direct access to Pharmawire journalists to gain additional detail on their articles and stories. “This is proprietary forward-looking content that isn’t available through any other sources,” said Jason Krantz, Infinata’s CEO. “We have significantly enhanced BioPharm Insight by including Pharmawire intelligence.”
Notable among its updates: customers now have access to the entire suite of BioPharm databases which provide detailed information on medical devices, licensing deals, and pharmaceutical sales and projections on marketed and pipeline drug products.
The new BioPharm Insight Suite is now available to new and existing Infinata customers.